The agreement provides the Buoy Suspension Fractional System for use in a clinical trial for rotator cuff tear repair with Ortho-R Chitosan-PRP hybrid drug/biologic.
The transaction includes GUIDOR bone graft substitutes known as easy-graft and calc-i-oss, and builds on the company's strategy to expand its technologies.